← Back to All Filings

Hologic CFO Awarded 17,095 Performance Stock Units

Low SignificanceNovember 6, 2025 at 5:04:26 PM EST

HOLOGIC INC

$HOLX4CIK: 0000859737

Subscribe to track HOLX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Hologic CFO Awarded 17,095 Performance Stock Units

Company: HOLOGIC INC (HOLX) Form: 4 | Filed: 2025-11-06 Significance: Low

Insider: Oberton Karleen Marie Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 17,095 • Price: $0.00 • Value: $0 • Owned After: 119,203

Key Insight: Routine grant of performance stock units to the CFO as part of an established compensation plan. The transaction has no cash value and does not reflect an open-market decision.

Market Context: The grant represents a negligible 0.008% of total shares outstanding for the $16.49B company, indicating minimal dilution or market impact.

Comprehensive Analysis

SEC Filing Analysis: HOLOGIC INC (HOLX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Hologic's CFO, Karleen Marie Oberton, was awarded 17,095 performance stock units as part of her compensation package.
  • Market Impact: Neutral. This is a non-cash, routine grant with negligible impact on the company's market capitalization or share structure.

Company Information

FieldValue
CompanyHOLOGIC INC
Ticker SymbolHOLX
CIK0000859737
IndustryX-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS

Insider Information

FieldValue
NameOberton Karleen Marie
CIK0001314036
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-04
Transaction CodeA (Award)
Security TypeCommon Stock (via Performance Stock Units)
Shares Involved17,095
Price Per Share$0.00
Total Value$0
Shares Owned After119,203
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted17,095
% of Shares Outstanding0.008%
Post-Transaction Ownership119,203 shares (0.054% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has no monetary value and is immaterial against Hologic's $16.49 billion market capitalization.
  • Ownership Concentration: The CFO's post-transaction ownership remains very low at 0.054% of total shares outstanding.
  • Dilution Impact: The grant results in a minor potential dilution of 0.008%, which is a standard and expected part of executive compensation for a company of this size.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a scheduled compensation-related grant, not an open-market transaction. It does not signal any new information about the insider's view of the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction is not a market trade and will not affect trading volume.
  • Sentiment Indicator: Neutral. The market typically views such routine grants as standard business practice.

Additional Context

Transaction Notes

  • The filing indicates these are Performance Stock Units (PSUs) where performance criteria have been met. The shares remain subject to service-based vesting requirements, as noted in the filing's footnotes.
Topics:#SECFiling#InsiderTrading#HOLX#Hologic#Form4#StockGrant#ExecutiveComp#CFO#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.